Navigation Links
BioSpecifics Technologies Corp. to Webcast, Live, at RetailInvestorConferences.com on December 6th
Date:12/4/2012

NEW YORK, Dec. 4, 2012 /PRNewswire/ -- RetailInvestorConferences.com is pleased to announce that BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in Europe and Eurasia, will present at RetailInvestorConferences.com. BioSpecifics' President Tom L. Wegman will be speaking directly to investors.

DATE:  

December 6, 2012

TIME:   

3:00 PM EST

LINK:

www.retailinvestorconferences.com > red "register / watch event now" button

This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

It is recommended that investors pre-register to save time and receive event updates.

BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. (Nasdaq GM: BSTC) is a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications. Injectable collagenase is currently marketed as XIAFLEX® in the U.S. for the treatment of adult Dupuytren's contracture patients with a palpable cord by Auxilium Pharmaceuticals, Inc. (Auxilium) and is approved for Dupuytren's contracture in the European Union and Canada. XIAFLEX is also in clinical development for the treatment of several additional promising indications: Auxilium recently submitted a supplemental Biologics License Application (sBLA) to the FDA for XIAFLEX for the potential treatment of Peyronie's disease based on positive results reported from its two Phase III clinical studies. Auxilium is also testing XIAFLEX for frozen shoulder syndrome (adhesive capsulitis) and cellulite in Phase IIa and Phase Ib clinical trials, respectively. BioSpecifics is currently managing the clinical development of XIAFLEX for the treatment of human lipoma and canine lipoma, which are both in Phase II clinical trials. Auxilium is currently partnered with Asahi Kasei Pharma Corporation for the development and commercialization of injectable collagenase for Dupuytren's contracture and Peyronie's disease in Japan and with Actelion Pharmaceuticals Ltd. for these same indications in Canada, Australia, Brazil and Mexico. Pfizer Inc. has marketing rights to XIAPEX® (the EU trade name for XIAFLEX) for Dupuytren's contracture in 46 countries in Eurasia through April 24, 2013.  For more information, please visit www.biospecifics.com.

About RetailInvestorConferences.com:

Since 2010, RetailInvestorConferences.com has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.


'/>"/>
SOURCE RetailInvestorConferences.com
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2012 Financial Results on November 8, 2012
2. BioSpecifics Technologies Corp. to Present at Two Upcoming Investor Conferences in September
3. BioSpecifics Technologies Corp. To Present at Stifel Nicolaus Weisel Healthcare Conference 2012
4. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2012 Financial Results on August 9, 2012
5. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
6. UV Flu Technologies Signs a Distribution Agreement with DPG Distribution
7. Alliqua Names David Johnson Executive Chairman of Aquamed Technologies and Member of Alliqua Board of Directors
8. DenMat Announces Signing a Purchase Agreement to Acquire PeriOptix Inc., Leading Provider of Magnification and Illumination Technologies
9. Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking
10. CLAAD Selects Egalet As Top Five Technologies To Reduce Prescription Drug Abuse Honoree
11. CLAAD Highlights 5 Technologies To Reduce Prescription Drug Abuse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2020)... ... March 30, 2020 , ... “In the time of remote ... hear stories from our customers of vendor price-gouging. We are here to promise ... hardships in this difficult time,” says Borya Shakhnovich, CEO of airSlate -- parent ...
(Date:3/28/2020)... ... March 27, 2020 , ... ... International has named Gary Gallant as its permanent CIO. In this executive ... technology vision, ensuring Isagenix can provide a smooth shopping experience for customers and ...
(Date:3/27/2020)... ... March 27, 2020 , ... Shady Grove Fertility (SGF) ... to board certified fertility specialists through virtual physician consults , thereby minimizing interruptions ... of SGF over its 29 year history has always been to improve access to ...
Breaking Medicine Technology:
(Date:4/1/2020)... ... April 01, 2020 , ... “Medical information is considered ... says Keller Grover LLP attorney Eric A. Grover. “For that reason, healthcare ... negligent release and disclosure of medical information can, under certain circumstances, give rise ...
(Date:3/28/2020)... N.J. (PRWEB) , ... March 27, 2020 , ... ... services division of the Suntuity Group of companies, is mobilizing their drone equipment ... COVID-19 coronavirus. , By leveraging their DJI Enterprise level Matrice and Agras drones, ...
(Date:3/28/2020)... S.C. (PRWEB) , ... March 27, 2020 , ... ... orthopedic practice OrthoSC is now offering telemedicine as an alternative approach ... one of the practice’s doctors in the comfort of their own home or ...
(Date:3/28/2020)... (PRWEB) , ... March 28, 2020 , ... ... Paso Physical Therapy Services (EPPTS), a physical therapist-owned rehabilitation company since 1985 specializing ... El Paso, TX. , “Since we started more than 30 years ago, we ...
(Date:3/27/2020)... ... March 27, 2020 , ... NeoTract, a ... the field of urology, today announced that Harpreet Wadhwa, M.D., East Valley Urology ... The designation recognizes that Dr. Wadhwa has achieved a high level of training ...
Breaking Medicine News(10 mins):